[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Just et al., 1995 - Google Patents

Glucosylation of Rho proteins by Clostridium difficile toxin B

Just et al., 1995

Document ID
7430731836821631652
Author
Just I
Selzer J
Wilm M
Eichel-Streiber C
Mann M
Aktories K
Publication year
Publication venue
Nature

External Links

Snippet

Abstract TOXIN A and B, the major virulence factors of Clostridium difficile, are the causative agents of antibiotic-associated pseudomembran-ous colitis. In cultured cell lines their potent cytotoxicity results from their ability to induce disaggregation of the microfilament …
Continue reading at www.nature.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Just et al. Glucosylation of Rho proteins by Clostridium difficile toxin B
Baeg et al. The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase.
US6316208B1 (en) Methods for determining isolated p27 protein levels and uses thereof
Craig et al. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers
Ridley et al. rho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivo.
Hulme et al. A novel leucine zipper targets AKAP15 and cyclic AMP-dependent protein kinase to the C terminus of the skeletal muscle Ca2+ channel and modulates its function
Tassan et al. In vitro assembly of a functional human CDK7‐cyclin H complex requires MAT1, a novel 36 kDa RING finger protein.
US5411860A (en) Amplification of human MDM2 gene in human tumors
Reuther et al. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family
Wu et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
US5582995A (en) Methods of screening for compounds which inhibit the direct binding of Ras to Raf
WO1998034121A9 (en) Isolated p27 protein and methods for its production and use
JP2000513805A (en) Methods and means for inhibiting Cdk4 activity
US5744313A (en) Assay employing novel protein domain which binds tyrosine phosphorylated proteins
Deng et al. Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts
Petropoulos et al. Human T cell leukemia virus type 1 Tax protein increases NF-κB dimer formation and antagonizes the inhibitory activity of the IκBα regulatory protein
AU747594B2 (en) Assays, therapeutic methods and means
McIlhinney et al. Immunocytochemical Characterization and Subcellular Localization of Human Myristoyl-CoA: ProteinN-Myristoyltransferase in HeLa Cells
US7150968B2 (en) Bridging INtegrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor
Dail et al. SHEP1 function in cell migration is impaired by a single amino acid mutation that disrupts association with the scaffolding protein cas but not with Ras GTPases
EP1572092A2 (en) Mk2 interacting proteins
Watanabe et al. Molecular properties, substrate specificity and regulation of DNA-dependent protein kinase from Raji Burkitt's lymphoma cells
US20050037446A1 (en) Agents that recognize src when phosphorylated at serine 17
Kawano et al. A monoclonal antibody against insect CALNUC recognizes the prooncoprotein EWS specifically in mammalian cells. Immunohistochemical and biochemical studies of the antigen in rat tissues
US20020110851A1 (en) Novel polypeptides, modulatory agents therefor and methods of using them